JASON SHAVER: Open Payments
NPI 1013231950 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 76 payments from 23 companies in 2025. Trend: 2023 $1,194 · 2024 $1,454 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $297 |
| Regeneron Healthcare Solutions, Inc. | 7 | $192 |
| GlaxoSmithKline, LLC. | 9 | $136 |
| Insmed, Inc. | 5 | $119 |
| JAZZ PHARMACEUTICALS INC. | 4 | $86 |
| Viatris Specialty LLC | 5 | $84 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Grifols USA, LLC | 3 | $62 |
Products named: DUPIXENT, NUCALA, Arikayce, FASENRA, XYWAV, YUPELRI, BREZTRI, ZERBAXA.
Industry payments across MO — which companies pay providers there.
